CS193019B2 - Method of producing 15alpha-methylene-4-estrene-17beta-ols - Google Patents

Method of producing 15alpha-methylene-4-estrene-17beta-ols

Info

Publication number
CS193019B2
CS193019B2 CS73748A CS74873A CS193019B2 CS 193019 B2 CS193019 B2 CS 193019B2 CS 73748 A CS73748 A CS 73748A CS 74873 A CS74873 A CS 74873A CS 193019 B2 CS193019 B2 CS 193019B2
Authority
CS
Czechoslovakia
Prior art keywords
15alpha
estrene
17beta
ols
methylene
Prior art date
Application number
CS73748A
Other languages
Czech (cs)
English (en)
Inventor
Rudolf Wiechert
Hermann Steinbeck
Walter Elger
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Priority to CS774125A priority Critical patent/CS193048B2/cs
Publication of CS193019B2 publication Critical patent/CS193019B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CS73748A 1972-02-11 1973-01-31 Method of producing 15alpha-methylene-4-estrene-17beta-ols CS193019B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS774125A CS193048B2 (en) 1972-02-11 1977-06-22 Process for preparing 15alpha,16alpha-methylen-4-estren-17beta-oles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2207421A DE2207421C3 (de) 1972-02-11 1972-02-11 15α, 16α -Methylen-4-östren-17β -ole bzw. -acylate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
CS193019B2 true CS193019B2 (en) 1979-09-17

Family

ID=5836211

Family Applications (1)

Application Number Title Priority Date Filing Date
CS73748A CS193019B2 (en) 1972-02-11 1973-01-31 Method of producing 15alpha-methylene-4-estrene-17beta-ols

Country Status (29)

Country Link
JP (1) JPS5829317B2 (ro)
KR (1) KR780000156B1 (ro)
AT (1) AT327413B (ro)
AU (1) AU467306B2 (ro)
BE (1) BE795241A (ro)
CA (1) CA997753A (ro)
CH (2) CH593995A5 (ro)
CS (1) CS193019B2 (ro)
DD (1) DD102379A5 (ro)
DE (1) DE2207421C3 (ro)
DK (1) DK131037B (ro)
EG (1) EG10914A (ro)
ES (1) ES410933A1 (ro)
FI (1) FI52225C (ro)
FR (1) FR2181719B1 (ro)
GB (1) GB1425636A (ro)
GR (1) GR63160B (ro)
HU (1) HU165253B (ro)
IE (1) IE37266B1 (ro)
IL (1) IL41506A (ro)
NL (1) NL177217C (ro)
NO (2) NO140304C (ro)
PH (1) PH9370A (ro)
PL (1) PL81084B1 (ro)
RO (1) RO73527A (ro)
SE (3) SE403781B (ro)
SU (1) SU513628A3 (ro)
YU (1) YU35035B (ro)
ZA (1) ZA73944B (ro)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007027637A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel
DE102007027636A1 (de) 2007-06-12 2008-12-18 Bayer Schering Pharma Aktiengesellschaft 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT274653B (de) * 1966-11-10 1969-09-25 Alexander Schoeller & Co Kg Stapelbarer, quaderförmiger, geschlossener Transportbehälter aus Kunststoff für feinkörnige Schüttgüter und Flüssigkeiten

Also Published As

Publication number Publication date
NL177217C (nl) 1985-08-16
IE37266B1 (en) 1977-06-08
AU467306B2 (en) 1975-11-27
FR2181719A1 (ro) 1973-12-07
EG10914A (en) 1976-09-30
NO140304C (no) 1979-08-08
SE403781B (sv) 1978-09-04
CH593995A5 (ro) 1977-12-30
DE2207421A1 (de) 1973-08-16
RO73527A (ro) 1982-02-01
IL41506A (en) 1976-07-30
FI52225B (ro) 1977-03-31
DD102379A5 (ro) 1973-12-12
CA997753A (en) 1976-09-28
AU5207673A (en) 1974-08-15
GB1425636A (en) 1976-02-18
FI52225C (fi) 1977-07-11
GR63160B (en) 1979-09-25
DE2207421B2 (de) 1980-07-24
ZA73944B (en) 1973-11-28
HU165253B (ro) 1974-07-27
ES410933A1 (es) 1976-03-01
SE7713896L (sv) 1977-12-07
YU24373A (en) 1979-12-31
CH590883A5 (ro) 1977-08-31
BE795241A (fr) 1973-08-09
PH9370A (en) 1975-10-22
SE7514513L (sv) 1975-12-22
NL7301974A (ro) 1973-08-14
NO140304B (no) 1979-04-30
AT327413B (de) 1976-01-26
DK131037B (da) 1975-05-20
KR780000156B1 (en) 1978-05-02
NO143065C (no) 1980-12-10
SE426834B (sv) 1983-02-14
SE409329B (sv) 1979-08-13
FR2181719B1 (ro) 1975-11-21
ATA112473A (de) 1975-04-15
JPS5829317B2 (ja) 1983-06-22
NO782754L (no) 1973-08-14
DE2207421C3 (de) 1981-05-07
IL41506A0 (en) 1973-04-30
IE37266L (en) 1973-08-11
NL177217B (nl) 1985-03-18
PL81084B1 (ro) 1975-08-30
SU513628A3 (ru) 1976-05-05
JPS4886856A (ro) 1973-11-15
NO143065B (no) 1980-09-01
YU35035B (en) 1980-06-30
DK131037C (ro) 1975-10-20

Similar Documents

Publication Publication Date Title
CS182791B2 (en) Method for production of substituted ce-pentanorprostaglandins
CS186710B2 (en) Method of producing bis-/4-hydroxyphenyl/alkanacids
CS183722B2 (en) Method for producing 3-hydroxycephalosporines
CS183686B2 (en) Method of producing 1-hydroxy-2-pyridones
CS183721B2 (en) Method of production of alfa-aminoacylcephalosporines
CA1008847A (en) Method of producing dl-methionyl-dl-methionine
CS182248B2 (en) Method of producing n-benzhydryl-n-p-hydroxy-benzylpiperazine
CS192504B2 (en) Method of producing cyano-methyl-thioacetyl-cephalosporins
CS191212B2 (en) Method of producing lysergamides
CS190393B2 (en) Method of producing antibiotic a-2315
BG24662A3 (en) Method of preparing d-1-11-15-dideoxoprostagland ne-e1
CS182781B2 (en) Method of producing 2,6-diaminodihydropyridines
CS183691B2 (en) Method for producing alkylsulphobenzylpenicillins
GB1414680A (en) Methods of forming die sections
CS188175B2 (en) Method of producing 15-substituted omega-nor-prostaglandins
CS181234B2 (en) Method of producing benzodioxol derivatives
CS181238B2 (en) Method of preparing 2-benzoyl-3-aminopyridines
CS183678B2 (en) Method of producing new alfa-/o-sulphobenzimido/lactames
IT1006116B (it) Metodo per produrre l serina
CS187377B2 (en) Method of producing novel cyclohexone derivatives
KR780000447B1 (en) Method of producing benzylamine
CS193022B2 (en) Method of producing derivatives of phosphonourea or phosphonothiourea
CS193019B2 (en) Method of producing 15alpha-methylene-4-estrene-17beta-ols
CS178903B2 (en) Method of producing urethans
JPS51125018A (en) Method of producing teromerized polyamide